These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Activity, assay and target data curation and quality in the ChEMBL database. Papadatos G; Gaulton A; Hersey A; Overington JP J Comput Aided Mol Des; 2015 Sep; 29(9):885-96. PubMed ID: 26201396 [TBL] [Abstract][Full Text] [Related]
6. Investigating the correlations among the chemical structures, bioactivity profiles and molecular targets of small molecules. Cheng T; Wang Y; Bryant SH Bioinformatics; 2010 Nov; 26(22):2881-8. PubMed ID: 20947527 [TBL] [Abstract][Full Text] [Related]
7. BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology. Gilson MK; Liu T; Baitaluk M; Nicola G; Hwang L; Chong J Nucleic Acids Res; 2016 Jan; 44(D1):D1045-53. PubMed ID: 26481362 [TBL] [Abstract][Full Text] [Related]
9. Collation and data-mining of literature bioactivity data for drug discovery. Bellis LJ; Akhtar R; Al-Lazikani B; Atkinson F; Bento AP; Chambers J; Davies M; Gaulton A; Hersey A; Ikeda K; Krüger FA; Light Y; McGlinchey S; Santos R; Stauch B; Overington JP Biochem Soc Trans; 2011 Oct; 39(5):1365-70. PubMed ID: 21936816 [TBL] [Abstract][Full Text] [Related]
10. Chemogenomics approaches for receptor deorphanization and extensions of the chemogenomics concept to phenotypic space. van der Horst E; Peironcely JE; van Westen GJ; van den Hoven OO; Galloway WR; Spring DR; Wegner JK; van Vlijmen HW; Ijzerman AP; Overington JP; Bender A Curr Top Med Chem; 2011; 11(15):1964-77. PubMed ID: 21470175 [TBL] [Abstract][Full Text] [Related]
12. BindingDB and ChEMBL: online compound databases for drug discovery. Wassermann AM; Bajorath J Expert Opin Drug Discov; 2011 Jul; 6(7):683-7. PubMed ID: 22650976 [TBL] [Abstract][Full Text] [Related]
13. A new ChEMBL dataset for the similarity-based target fishing engine FastTargetPred: Annotation of an exhaustive list of linear tetrapeptides. Tanwar S; Auberger P; Gillet G; DiPaola M; Tsaioun K; Villoutreix BO Data Brief; 2022 Jun; 42():108159. PubMed ID: 35496477 [TBL] [Abstract][Full Text] [Related]
14. Chemogenomic data analysis: prediction of small-molecule targets and the advent of biological fingerprint. Bender A; Young DW; Jenkins JL; Serrano M; Mikhailov D; Clemons PA; Davies JW Comb Chem High Throughput Screen; 2007 Sep; 10(8):719-31. PubMed ID: 18045083 [TBL] [Abstract][Full Text] [Related]
15. Quantitatively integrating molecular structure and bioactivity profile evidence into drug-target relationship analysis. Xu T; Zhu R; Liu Q; Cao Z BMC Bioinformatics; 2012 May; 13():75. PubMed ID: 22559876 [TBL] [Abstract][Full Text] [Related]
17. Identifying Differences in the Performance of Machine Learning Models for Off-Targets Trained on Publicly Available and Proprietary Data Sets. Smajić A; Rami I; Sosnin S; Ecker GF Chem Res Toxicol; 2023 Aug; 36(8):1300-1312. PubMed ID: 37439496 [TBL] [Abstract][Full Text] [Related]
18. Making every SAR point count: the development of Chemistry Connect for the large-scale integration of structure and bioactivity data. Muresan S; Petrov P; Southan C; Kjellberg MJ; Kogej T; Tyrchan C; Varkonyi P; Xie PH Drug Discov Today; 2011 Dec; 16(23-24):1019-30. PubMed ID: 22024215 [TBL] [Abstract][Full Text] [Related]
19. The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Pawson AJ; Sharman JL; Benson HE; Faccenda E; Alexander SP; Buneman OP; Davenport AP; McGrath JC; Peters JA; Southan C; Spedding M; Yu W; Harmar AJ; Nucleic Acids Res; 2014 Jan; 42(Database issue):D1098-106. PubMed ID: 24234439 [TBL] [Abstract][Full Text] [Related]
20. What is the likelihood of an active compound to be promiscuous? Systematic assessment of compound promiscuity on the basis of PubChem confirmatory bioassay data. Hu Y; Bajorath J AAPS J; 2013 Jul; 15(3):808-15. PubMed ID: 23605807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]